Patients with vs without ANCA-associated vasculitis are significantly more likely to die after kidney transplantation and to experience postoperative infection. Patients with ANCA-associated ...

MANCHESTER, England — A soon-to-be-released guidance from the British Society for Rheumatology on the management of antineutrophil cytoplasmic antibody (ANCA)–associated vasculitis (AAV) emphasizes ...

AAV is diagnosed based on symptoms listed above and the following laboratory tests. Based on which organs that may not be functioning well, imaging or biopsy may be performed. ANCA test, which is a ...

Small studies have found that B-cell depletion with rituximab may be beneficial in refractory antineutrophil cytoplasmic antibody-associated (ANCA-associated) vasculitis, due to the presence of ...

Patients with GCA or AAV were associated with an increased risk for hospitalization due to pneumonia compared with members of the general population.

The FDA approved the oral complement 5a receptor inhibitor avacopan (Tavneos) for the treatment of severe, active antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis, drugmaker ...

The guideline recommends that glucocorticoids in combination with rituximab or cyclophosphamide be used as initial treatment for new-onset ANCA-associated vasculitis. The Kidney Disease: Improving ...

Conjunctivitis or episcleritis and scleritis comprised the most common eye manifestations, while cataracts (11.7%) and visual ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. SAN DIEGO — Approximately two-thirds of patients with ...

Please provide your email address to receive an email when new articles are posted on . DESTIN, Fla. — Despite advances in biologic therapies, “excess steroid use” remains a mainstay of treatment for ...

SAN CARLOS, Calif., Nov. 12, 2021 (GLOBE NEWSWIRE) -- ChemoCentryx, Inc., (Nasdaq: CCXI), today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use ...